The Schall Law Firm Urges Shareholders to Join Securities Fraud Case Against Capri Holdings Limited: Protect Your Investment Losses Today!

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Capri Holdings Limited Investor Alert: The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors of a class action lawsuit against Capri Holdings Limited (“Capri” or “the Company”) (NYSE:CPRI) for violations of 10(b) and 20(a) of the Securities Exchange Act of…

Read More

Bronstein Gewirtz Grossman LLC Launches Investigation into Allegations Against Vicor Corporation (VICR) – Stockholders Encouraged to Speak Out!

Welcome to New York City Investigation into Vicor Corporation New York City, NY / ACCESSWIRE / December 30, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation (“Vicor” or “the Company”) (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold…

Read More

Rosen Global Investor Counsel Encourages Investors of Transocean Ltd with Losses Over $100K to Secure Counsel Before Important Securities Class Action Deadline

NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of Transocean Ltd. (NYSE: RIG) securities between October 31, 2023 and September 9, 2024, both dates inclusive (the “Class Period”). A class action has already been…

Read More

Act Now: Protect Your Investment in Kyverna Therapeutics Inc. – Important Deadline Approaching, Says Rosen Global Investor Counsel

Rosen Law Firm Reminds Kyverna Therapeutics, Inc. Investors of February 7 Lead Plaintiff Deadline New York, NY / Accesswire / December 30, 2024 Rosen Law Firm, a global investor rights law firm, is reminding purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) about the upcoming lead plaintiff deadline. Investors who bought Kyverna common stock…

Read More

Calling All RIG Investors: Take Action with Robbins Geller Rudman & Dowd LLP for Transocean Ltd’s Class Action Lawsuit!

Recent Transocean Class Action Lawsuit A Closer Look at the Legal Battle Recently, Robbins Geller Rudman & Dowd LLP made an announcement that could potentially have significant implications for investors who purchased or acquired Transocean Ltd. securities between October 31, 2023 and September 2, 2024. The lawsuit, captioned Gábor v. Transocean Ltd., No. 24-cv-09964 (S.D.N.Y.),…

Read More

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

enGene Holdings Inc. Reports Grant of Inducement Equity Awards Introduction enGene Holdings Inc., a clinical-stage genetic medicines company, has announced the grant of inducement equity awards to its employees. The company, which is known for its non-viral lead investigational product detalimogene voraplasmid, is currently conducting a pivotal study in patients with high-risk, BCG-unresponsive, non-muscle invasive…

Read More